Abstract
Despite the importance of the myocardial lymphatic vasculature in many pathological conditions, little information is readily available about heart valvular lymphatic vessels in normal and pathological conditions. Before the onset of specific antibodies, researchers mainly performed dye and hydrogen peroxide injection studies in animal hearts in order to visualize the cardiac lymphatics. In the era of specific antibodies, lymphatic vessels were described in normal human valves. In pathological valves, the highest number of lymphatics was found in valves with infective endocarditis where they accounted for nearly 100 % of all vessels in extracellular matrix-rich areas whereas inflammatory cell-rich areas were more prone to angiogenesis. An increased number of lymphatics was also found in cases of degenerative calcified stenosis and myxoid degeneration whereas the number was unchanged in fibrotic valves. Knowledge of the lymphatics in cardiac valves and their changes under various pathological conditions is also important for the further development of various treatment strategies. Certain drugs or gene therapy techniques could potentially influence lymphatic vessel densities in these regions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Eberth CJ, Belajeff A (1866) Uber die Lymphagefässe des Herzens. Arch Path Anat 37:124–131
Aagaard OC (1924) Les Vaisseaux Lymphatique du Coeur Chez L’Homme et Chez Quelques Mammiferes. Levin and Munkegaard, Copenhagen
Patek P (1939) Morphology of the lymphatics of the mammalian heart. Am J Anat 64:203–234
Bradham RR, Parker EF, Greene WB (1973) Lymphatics of the atrioventricular valves. Arch Surg 106(2):210–213
Miller AJ, Pick R, Katz LN (1961) Lymphatics of the mitral valve of the dog. Demonstration and discussion of the possible significance. Circ Res 9:1005–1009
Noguchi T, Shimada T, Nakamura M, Uchida Y, Shirabe J (1988) The distribution and structure of the lymphatic system in dog atrioventricular valves. Arch Histol Cytol 51(4):361–370
Symbas PN, Schlant RC, Gravanis MB, Shepherd RL (1969) Pathologic and functional effects on the heart following interruption of the cardiac lymph drainage. J Thorac Cardiovasc Surg 57(4):577–584
Ullal SR, Kluge TH, Gerbode F (1972) Functional and pathologic changes in the heart following chronic cardiac lymphatic obstruction. Surgery 71(3):328–334
Johnson RA, Blake TM (1966) Lymphatics of the heart. Circulation 33(1):137–142
Eliskova M, Eliska O (1992) How lymph is drained away from the human papillary muscle: anatomical conditions. Cardiology 81(6):371–377
Riquet M, Le Pimpec BF, Souilamas R, Hidden G (2002) Thoracic duct tributaries from Âintrathoracic organs. Ann Thorac Surg 73(3):892–898; discussion 898–899
Sacchi G, Weber E, Agliano M, Cavina N, Comparini L (1999) Lymphatic vessels of the human heart: precollectors and collecting vessels. A morpho-structural study. J Submicrosc Cytol Pathol 31(4):515–525
Parke WW, Michels NA (1963) A method for demonstrating subserous lymphatics with hydrogen peroxide. Anat Rec 146:165–171
Bailey D, Baumal R, Law J, Sheldon K, Kannampuzha P, Stratis M et al (1986) Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 83(14):5291–5295
Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M et al (1999) Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 80(3–4):569–578
Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R et al (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151(4):1141–1152
Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG (2001) Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276(22):19420–19430
Mouta Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI et al (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61(22):8079–8084
Florez-Vargas A, Vargas SO, Debelenko LV, Perez-Atayde AR, Archibald T, Kozakewich HP et al (2008) Comparative analysis of D2-40 and LYVE-1 immunostaining in lymphatic malformations. Lymphology 41(3):103–110
Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98(6):769–778
Kholova I, Dragneva G, Cermakova P, Laidinen S, Kaskenpaa N, Hazes T et al (2011) Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-Ârich and calcified atherosclerotic lesions. Eur J Clin Invest 41(5):487–497
Nielsen JS, McNagny KM (2008) Novel functions of the CD34 family. J Cell Sci 121(pt 22):3683–3692
Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett MS, Bates DO et al (2006) The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol 168(3):1045–1053
Eom M, Choi YD, Kim YS, Cho MY, Jung SH, Lee HY (2007) Clinico-pathological characteristics of congenital pulmonary lymphangiectasis: report of two cases. J Korean Med Sci 22(4):740–745
Johnson RA (1969) The lymphatic system of the heart. Lymphology 2(3):95–108
Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1(3):219–227
Karkkainen MJ, Alitalo K (2002) Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Semin Cell Dev Biol 13(1):9–18
Schoen FJ (2005) The heart. In: Kumar V, Abbas AK, Fausto N (eds) Robbins and Cotran pathologic basis of diseases. Elsevier Saunders, Philadelphia, pp 555–618
von der Weid PY, Muthuchamy M (2010) Regulatory mechanisms in lymphatic vessel contraction under normal and inflammatory conditions. Pathophysiology 17(4):263–276
Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3:367–397
Kholova I, Laidinen S, Dragneva G, Hajkova P, Steiner I, Kosma V (2007) Lymphatic vessels, lymphatic vascular endothelial growth factors and their receptors in human heart valves. Virchows Arch 451:127
Soini Y, Salo T, Satta J (2003) Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum Pathol 34(8):756–763
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kholová, I., Dragneva, G., Ylä-Herttuala, S. (2013). The Lymphatics in Normal and Pathological Heart Valves. In: Karunamuni, G. (eds) The Cardiac Lymphatic System. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6774-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6774-8_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6773-1
Online ISBN: 978-1-4614-6774-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)